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Background: miRNAs are proved to have causal roles in tumorgenesis involving various types of human cancers,
but the mechanism is not clear. We aimed to explore the effect of miRNAs on the development of ovarian cancer
and the underlying mechanism.
Methods: The miRNA expression profile GSE31801 was downloaded from GEO (Gene Expression Omnibus)
database. Firstly, the differentially expressed miRNAs were screened. Target genes of the miRNAs were collected
from TargetScan, PicTar, miRanda, and DIANA-microT database, then the miRNA-miRNA co-regulating network was
constructed using miRNA pairs with common regulated target genes. Next, the functional modules in the network
were studied, the miRNA pairs regulated at least one modules were enriched to form the miRNA functional synergistic
network (MFSN).
Results: Risk miRNA were selected in MFSN according to the topological structure. Transcript factors (TFs) in MFSN
were identified, followed by the miRNA-transcript factor networks construction. Totally, 42 up- and 61 down-regulated
differentially expressed miRNAs were identified, of which 68 formed 2292 miRNA pairs in the miRNA-miRNA
co-regulating network. GO: 0007268 (synaptic transmission) and GO: 0019226 (transmission of nerve impulse)
were the two common functions of miRNAs in MFSN, and hsa-miR-579 (36), hsa-miR-942 (31), hsa-miR-105 (31),
hsa-miR-150 (34), and hsa-miR-27a* (32) were selected as the hub nodes in MFSN.
Conclusions: In all, 17 TFs, including CREM, ERG, and CREB1 were screened as the cancer related TFs in MFSN.
Other TFs, such as BIN1, FOXN3, FOXK1, FOXP2, and ESRRG with high degrees may be inhibited in ovarian cancer.
MFSN gave us a new shed light on the mechanism studies in ovarian cancer.
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Functional moduleIntroduction
Ovarian cancer is a cancerous growth arising from the
ovary, and a leading death from gynecologic malignancy
in the western world, with a 5-year survival rate of
approximately 30% in advanced-stage disease when
diagnosed [1]. The vague and nonspecific symptoms,
which usually appear when the patients has reached
an advanced stage, have led to the high case-fatality ratio
of ovarian cancer [2,3]. Thus, the molecular mechanism
study on ovarian cancer is of great importance for
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stated.MicroRNAs (miRNAs) control various cellular processes
through the post-transcriptional regulatory network.
The deregulation of miRNA is involved in the initiation
and progression of human cancer [4], and the studies
on ovarian cancer are widely conducted in the past few
years. Zhang et al. [5] carried an integrative genomic
approach for the identification of miRNA deregulation
in human epithelial ovarian cancer. They found that
miRNA expression was markedly down-regulated in
malignant transformation and tumor progression, contrib-
uting to a genome-wide transcriptional deregulation.
Resnick et al. [6] detected the differentially expressed
microRNAs from the serum of ovarian cancer using a
novel real-time PCR platform, and miRNAs-21, 92 and
93 were identified to be potential biomarkers. Oncogenicd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Ovarian cancer cells [7]. However, the potential mechan-
ism and its contributions to genome-wide transcriptional
changes in cancer are still remarkably unknown.
Synergistic regulations among multiple miRNAs are
important to understand the mechanisms of complex post-
transcriptional regulations in humans. Complex diseases,
especially cancers are affected by several miRNAs rather
than a single miRNA. Thus, it is a challenge to identify
miRNA synergistic functions and thereby further deter-
mine miRNA functions at a system level and investigateFigure 1 Co-regulating network of differentially expressed miRNAs. R
down-regulated miRNAs, and edges indicate that there are co-regulating tdisease miRNA features in the miRNA–miRNA synergistic
network (MFSN) from a new view [8]. miRNA synergetic
regulations are gradually identified by computational or ex-
perimental evidence. However, the potential characteristic
underlying miRNA synergism remains a mystery [9].
In this study, we attempted to systematically dissect
the risk miRNA of ovarian cancer, based on the con-
structed MFSN, from three levels: sequence, secondary
structure and transcriptional regulation. Briefly, differen-
tially expressed miRNAs were first identified, and then
based on the correlations between miRNAs and targeted nodes represent up-regulated miRNAs, green nodes represent
arget genes between the two miRNAs.
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structed, and based on the functional cluster of the net-
work, the MFSN was constructed. Next, the transcript
factors (TFs) in MSFN were screened, the miRNA-
transcript factors network was sequentially constructed.
Materials and methods
Affymetrix microarray analysis
We downloaded the miRNA expression profile data GSE
31801 [10] from NCBI (National Center for Biotechnology
Information) GEO (Gene Expression Omnibus) (http://
www.ncbi.nlm.nih.gov/geo/) database. Chips of miRNA
profiling in lymphoblastoid cell lines from 74 women with
familial ovarian cancer were available, as well as chips from
47 normal ovarian tissues. The annotation information of
the chip was also downloaded from GPL8179_human-
MI_V2_R0_XS0000124_MAP platform.
Data preprocessing
The original miRNA expression profile was first standard-
ized using median method [11]. Then the probe level dataFigure 2 Functional synergistic networks of differentially expressed m
are the down-regulated miRNAs. Edges represent the synergistic effect betwere converted into miRNA names, and only one miRNA
was chosen when there were more than one miRNAs
responding to a signal probe.Differentially expressed miRNAs analysis
To screen the differentially expressed miRNAs, limma
package in R language [12] was used, with the cut off
criterion of adjusted p value less than 0.05, and |log fold
change (FC)| larger than 1.5.miRNA-miRNA co-regulating network construction
TargetScan [13], PicTar [14], miRanda [15], and DIANA-
microT [16] database was used to predict the target genes
of miRNAs. Then the selected miRNAs-target genes
database was used for the identification of the target
genes of differentially expressed miRNAs. miRNA pairs
having same regulating target genes were selected for
the miRNA-miRNA co-regulating network construction
using cytoscape software [17].iRNAs. Red nodes are the up-regulated miRNAs, and the green nodes
ween miRNAs.
Figure 3 Distributions of function modules of synergistic miRNA pairs. Horizontal axis represents the count of function module, while
vertical axis represents the count of the miRNA pairs.
Table 1 Top 20 enriched biological process functions of
the miRNA functional synergistic network
Gene oncology (GO) biological process
(BP) term & description
Percent
GO:0007268 ~ synaptic transmission 0.867868
GO:0019226 ~ transmission of nerve impulse 0.864865
GO:0035637 ~multicellular organismal signaling 0.855856
GO:0007267 ~ cell-cell signaling 0.651652
GO:0050877 ~ neurological system process 0.582583
GO:0003008 ~ system process 0.51952
GO:0007399 ~ nervous system development 0.474474
GO:0044700 ~ single organism signaling 0.447447
GO:0023052 ~ signaling 0.447447
GO:0007154 ~ cell communication 0.447447
GO:0030182 ~ neuron differentiation 0.444444
GO:0048666 ~ neuron development 0.435435
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expressed miRNAs
For each miRNA pair, their co-regulating target genes
was identified as a target subset, and then ClusterProfiler
package [18] in R language was used to perform the
candidate biological process (BP) functional modules
identification. The threshold was set as p and q value
less than 0.05. If a pair of miRNAs significantly co-
regulated at least one functional module, the miRNAs
were considered as synergistic miRNAs [8]. All the
synergistic miRNA pairs were gathered to form a
MFSN. Next, igraph package [19] was used to calcu-
late the degrees of the nodes and the minimum radius
of the MFSN. The numbers and the Gene Oncology
(GO) BP terms of functional modules in MFSN were
further analyzed.GO:0022008 ~ neurogenesis 0.432432
GO:0048731 ~ system development 0.42042
GO:0044707 ~ single-multicellular organism process 0.417417
GO:0048699 ~ generation of neurons 0.408408
GO:0007275 ~multicellular organismal development 0.408408
GO:0031175 ~ neuron projection development 0.396396
GO:0048646 ~ anatomical structure formation
involved in morphogenesis
0.381381
GO:0048812 ~ neuron projection morphogenesis 0.363363miRNA -transcription factor regulating
network construction
We first identified the transcription factors (TFs) of
the target genes in MFSN using TRANSFAC. Then we
constructed the miRNA-transcription factor regulating
network using the TFs and their interacted miRNAs.
Finally, TRED database [20] was used to screen the
verified cancer-related TFs in the network.
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Differentially expressed miRNAs
After preprocessing, we obtained the expression values of
1146 miRNAs of the 121 samples. In total, 42 up- and
61 down-regulated differentially expressed miRNAs were
identified. There were 42411 and 55775 corresponding tar-
get genes of up- and down-regulated miRNAs respectively.miRNA-miRNA co-regulating network construction
The common regulated target genes of each miRNA pair
were screened, and 2292 co-regulating pairs formed by a
total of 68 miRNAs shared at least one target gene were
screened, including 34 up-regulated miRNAs (Figure 1).MFSN network construction
GO terms enrichment of each miRNA pair in the co-
regulating network was conducted, then, miRNA pairs
regulating at least one functional module were collected
to construct the MFSN network. There were 333 co-
regulating pairs formed by 41 miRNAs (Figure 2) in theFigure 4 The regulating network of 17 cancer related transcript facto
red nodes are the up-regulated miRNAs, and green nodes are the down-regunetwork, such as hsa-miR-342-5p, hsa-miR-628-3p, hsa-
miR-600, and hsa-miR-647.
Next, we discussed the structure and organization of the
MFSN. The MFSN was a small word with a short diam-
eter of 2, with a few miRNAs interacted with a relatively
large number of miRNA partners, and many miRNAs
have few miRNA partners. In all, 5 nodes with degrees
more than 30, including hsa-miR-579 (36), hsa-miR-942
(31), hsa-miR-105 (31), hsa-miR-150 (34), and hsa-
miR-27a* (32) were selected as the hub nodes in MFSN.
Besides has-miR-579, the other four nodes were up-
regulated differentially expressed miRNAs. Hub nodes
with high degrees in MFSN have more close association
with other miRNAs in function, thus are considered as
risk miRNAs.
Functional modules in MFSN analysis
The examination of number distribution of co-regulating
functional modules revealed a power law tendency. In
total, 73.3% miRNAs pairs (244) were involved in at
least 5 modules (Figure 3), suggesting that these miRNAsrs (TFs) and differentially expressed miRNAs. Blue nodes are the TFs,
lated miRNAs. Edges represent the interactions between TFs and miRNAs.
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of ovarian, the up-/down-regulation of miRNAs would
cause the dysfunctions of many BPs. The miRNA pair
of hsa-miR-942 and hsa-miR-33a had the highest function
module number of 279, and hsa-miR-942 as a hub node in
MFSN, was synergistic with 31 miRNAs. Hsa-miR-942
was an up-regulated, while hsa-miR-33a was a down-
regulated miRNAs in ovarian cancer.
Next, we analyzed the distributions of GO BP terms
enriched in MFSN. More than 85% miRNAs were enriched
in the function module of GO: 0007268 (synaptic transmis-
sion) and GO: 0019226 (transmission of nerve impulse).
As shown in Table 1 (the top 20 enriched functional
modules), signal transduction related functions were the
most frequent functions of the miRNAs in MFSN.miRNA -transcription factor regulating network
Corresponding to the 2117 genes participated in the
functional modules in MFSN, 90 TFs were identified.
Then the miRNA-transcription factor regulating network
was constructed (Figure 4). The TFs were mapped to
TRED database, a total of 17 cancer related TFs coming
from 13 TFs family were identified (Table 2). CREM, ERG,
and CREB1 had the highest degrees among the 17 TFs,
that is, 55, 38, and 28 respectively. They were collected for
the construction of a new miRNA-transcription factor
regulating network (Figure 5). In the rest 73 TFs among
all the 90 target genes, BIN1 (26), FOXN3 (29), FOXK1
(31), FOXP2 (32), and ESRRG (42) were the top 5 TFs
ranked by the numbers of miRNAs interacted with them.Table 2 Cancer related transcript factors in the miRNA functio


















In order to obtain an in-depth analysis of individual
miRNAs in the context of their synergistic surroundings,
MFSN of differentially expressed miRNAs was constructed
via co-regulating functional modules. Furthermore, the
underlying functional patterns of risk miRNAs in ovarian
cancer were also reported in this study. Among all the 103
differentially expressed miRNAs, 68 miRNAs formed 2292
pairs which shared at least one target genes. There were 41
miRNAs (333 miRNA pairs) in the miRNA-miRNA co-
regulating shared at least one significant functional module.
In addition, GO: 0007268 synaptic transmission and
GO: 0019226 transmission of nerve impulse were the
most common functional modules of miRNAs in MFSN.
According to their degrees in MFSN, hsa-miR-579, hsa-
miR-942, hsa-miR-105, hsa-miR-150, and hsa-miR-27a*
were selected as hub nodes in MFSN. What’s more, 17
cancer-related TFs were identified in MFSN, which were
further used for the miRNA-transcript factors network
construction.
The selected 5 hub miRNAs in MFSN all had the degree
more than 30, and they were considered as the potential
ovarian cancer-related risk miRNAs, whose alternations
were related to the dysfunctions of many BPs in ovarian
cancer tissues. Hsa-miR-579 was a down-regulated miRNA
of ovarian cancer samples, and miR-579 is found to dys-
regulated in colorectal cancer with liver metastasis [21].
The other four miRNAs, hsa-miR-942, hsa-miR-105,
hsa-miR-150, and hsa-miR-27a* were identified to be
up-regulated in ovarian cancer. The miRNA pairs com-
prised of hsa-miR-33a and hsa-miR-942 accounted fornal synergistic network
ull name Degree
ypoxia-inducible factor 10
ctivating transcription factor 8
ctivating transcription factor 19
-cell CLL/lymphoma 3
reast cancer susceptibility protein 5
AMP responsive element binding protein 28
AMP responsive element binding protein 55
2F transcription factor 14
arly growth response protein 8
ember of ETS oncogene family 5
ts-related gene 38
strogen receptor 3
TS-domain transcription factor 13
TS-domain transcription factor 3
ctivator protein 1 8
lioma-associated oncogene homolog 17
ypoxia-inducible factor 7
Figure 5 The regulating network of 3 main cancer related transcript factors (TFs) and differentially expressed miRNAs. Blue nodes are
the TFs, red nodes are the up-regulated miRNAs, and green nodes are the down-regulated miRNAs. Edges represent the interactions between
TFs and miRNAs.
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31 miRNAs interacted with hsa-miR-942 in MFSN,
suggesting they were functionally synergistic with hsa-
miR-942 and the expression changes of hsa-miR-942 in
ovarian cancer may cause the changes of these connected
miRNAs as well. The expression of miR-942 is signifi-
cantly increased in patients with biliary tract cancer [22],
and in late recurrent hepatocellular carcinoma samples
[23]. In the formalin-fixed squamous cell carcinomas of
the tongue, hsa-miR-105 is one of the up-regulated
miRNAs [24], and highly expressed in seminoma [25].
Secreted monocytic miR-150 could enhance the tar-
geted endothelial cell migration [26], and hsa-miR-150
is found to be differentially expressed in lung cancer
tissues [27]. Hsa-miR-150 is recommended to be used
as a circulating cancer marker [28]. In addition, hsa-miR-27a is reportedly down-regulated in many cancers,
including breast and prostate cancer [29].
The common functional modules of miRNAs in MFSN
were screened by calculating the GO BP terms distribution.
It turned out that these miRNAs were mainly partici-
pated in signal transduction related functions, with synap-
tic transmission and transmission of nerve impulse as the
most significant ones. Synaptic transmission is the process
by which neurotransmitters are released, and bind to the
receptors of another neuron. Nerve impulses are essential
for the propagation of the signals [30]. The dysfunction
of transmission of nerve impulse meant that the signal
transmission was impaired in the development of ovarian
cancer. The up-regulated genes in gliomas are associated
with several processes, such as synaptic transmission and
transmission of nerve impulse [31].
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element-binding modulator) is highly expressed inpost-
meiotic cells [32]. Down-regulated CREM modulates the
transcription of several genes containing a cAMP respon-
sive element motif in their promoter region [33]. CREM
expression has been linked with several key physiological
aspects of neuroendocrine pathways [34]. The aberrant
expression of ERG (ETS transcription factor ) is demon-
strated to be progression events in prostate tumorigenesis
[35]. CREB1 (cAMP response element-binding protein 1)
transduces cell survival responses to peptide hormones
and growth factors in normal tissues, and mutant CREB
proteins are implicated in tumorigenesis [36]. The TFs of
CREM, ERG, and CREB1 were found to be regulated by
several miRNAs in this study, which will influence the
expressions of their target genes. The encoded genes by
these TFs were potentially inhibited in ovarian cancer,
as well as the regulations on the downstream target
genes. What’s more, BIN1, FOXN3, FOXK1, FOXP2,
and ESRRG were the top 5 TFs ranked by the numbers
of miRNAs interacted with them, and their functions
were inferred to be inhibited in ovarian cancer.
Conclusion
In conclusion, risk miRNAs in ovarian cancer along with
the interacted miRNAs can be detected by means of
MFSN construction. The further study on the functional
modules and TFs connection will provide a new approach
on the mechanism study on miRNAs alternations in
ovarian cancer.
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